These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33217585)

  • 1. The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation.
    Lu Q; Jiang Z; Wang Q; Hu H; Zhao G
    Ann Hepatol; 2021; 23():100289. PubMed ID: 33217585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
    Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
    Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
    Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
    Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
    Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota.
    Shen S; Huang D; Qian S; Ye X; Zhuang Q; Wan X; Dong Z
    Eur J Pharmacol; 2023 Sep; 955():175891. PubMed ID: 37429516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.
    Xie Y; Newberry EP; Kennedy SM; Luo J; Davidson NO
    J Lipid Res; 2009 May; 50(5):977-87. PubMed ID: 19136665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Rhythm Disruption Influenced Hepatic Lipid Metabolism, Gut Microbiota and Promoted Cholesterol Gallstone Formation in Mice.
    He C; Shen W; Chen C; Wang Q; Lu Q; Shao W; Jiang Z; Hu H
    Front Endocrinol (Lausanne); 2021; 12():723918. PubMed ID: 34745000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion.
    Hu H; Shao W; Liu Q; Liu N; Wang Q; Xu J; Zhang X; Weng Z; Lu Q; Jiao L; Chen C; Sun H; Jiang Z; Zhang X; Gu A
    Nat Commun; 2022 Jan; 13(1):252. PubMed ID: 35017486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?
    Li Y; Li M; Wu S; Tian Y
    Lipids Health Dis; 2015 Sep; 14():100. PubMed ID: 26335572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism.
    Ye X; Shen S; Xu Z; Zhuang Q; Xu J; Wang J; Dong Z; Wan X
    Eur J Pharmacol; 2021 Oct; 908():174341. PubMed ID: 34273384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauroursodeoxycholic Acid Improves Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism.
    Wang H; Guo Y; Han W; Liang M; Xiao X; Jiang X; Yu W
    J Agric Food Chem; 2024 Sep; 72(36):20194-20210. PubMed ID: 39193771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
    Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
    Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
    Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe prevents cholesterol gallstone formation in mice.
    Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
    Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1.
    Lin J; Shao WQ; Chen QZ; Zhu WW; Lu L; Jia HL; Chen JH
    Mol Med Rep; 2017 Aug; 16(2):1785-1792. PubMed ID: 28627641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
    Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
    Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones.
    Henkel A; Wei Z; Cohen DE; Green RM
    Mamm Genome; 2005 Dec; 16(12):903-8. PubMed ID: 16341669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice.
    Dorvash MR; Khoshnood MJ; Saber H; Dehghanian A; Mosaddeghi P; Firouzabadi N
    Eur J Pharmacol; 2018 Aug; 833():165-172. PubMed ID: 29883669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice.
    Shen W; Shao W; Wang Q; Wang B; Zhao G; Gu A; Jiang Z; Hu H
    J Biomed Sci; 2023 Jun; 30(1):44. PubMed ID: 37370162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.